1.1.1.132: GDP-mannose 6-dehydrogenase
This is an abbreviated version!
For detailed information about GDP-mannose 6-dehydrogenase, go to the full flat file.
Word Map on EC 1.1.1.132
-
1.1.1.132
-
aeruginosa
-
alginate
-
cystic
-
fibrosis
-
mucoid
-
mannuronic
-
midecamycin
-
sputum
-
vinelandii
-
molecular-genetic
-
azotobacter
-
erythromycin
-
macrolide
-
elastase
-
chemoenzymatic
-
gdpmannose
-
multidrug-resistant
- 1.1.1.132
- aeruginosa
- alginate
-
cystic
- fibrosis
- mucoid
-
mannuronic
- midecamycin
-
sputum
- vinelandii
-
molecular-genetic
-
azotobacter
- erythromycin
-
macrolide
- elastase
-
chemoenzymatic
- gdpmannose
-
multidrug-resistant
Reaction
Synonyms
algD, GDP mannose dehydrogenase, GDP-D-mannose dehydrogenase, GDP-mannose dehydrogenase, GMD, GMD1, GMD2, guanosine diphosphate mannose dehydrogenase, guanosine diphospho-D-mannose dehydrogenase, guanosine diphosphomannose dehydrogenase
ECTree
Advanced search results
Inhibitors
Inhibitors on EC 1.1.1.132 - GDP-mannose 6-dehydrogenase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
5'-(3-hydroxypropyl)-amino-5'-deoxy-guanosine
-
only after preincubation with enzyme
5'-azido-5'-deoxy-N2-2',3'-O-triacetylguanosine
-
only after preincubation with enzyme
5'[[[[(2'',3'',4'',6''-tetra-O-acetyl 6''-ethynyl)alpha-D-mannopyranosyl oxy]-carbonyl]amino]sulfonyl]-2',3'-isopropylidene N2-acetyl guanosine
-
GDP-analog, 0.1 mM, 60% inhibition
ambroxol
i.e. 2-amino-3,5-dibromo-N-[trans-4-hydroxycyclohexyl]benzylamine, inhibits GMD activity, reduces the production of alginate, the expression of the important genes, and affects the structure of mucoid Pseudomonas aeruginosa biofilms, overview; reduces activity of the key enzyme GMD in alginate biosynthesis in a concentration-dependent manner
erythromycin
-
potent dose-dependent inhibitory effect, inhibition of biofilm formation, PT-1578
iodacetamide
-
40% inactivation within 30 min, complete reactivation by dithiothreitol
N2-acetyl-2',3'-isopropylidene guanosine
-
only after preincubation with enzyme
N2-acetyl-5'-amino-5'-deoxy-2',3'-O-acetylguanosine
-
only after preincubation with enzyme
N2-acetyl-5'-amino-5'-deoxy-guanosine
-
only after preincubation with enzyme
p-hydroxymercuribenzoate
-
96% inactivation after 5 min preincubation; 96% inactivation within 5 min, complete reactivation by dithiothreitol
Zn2+
-
potent inhibitor with 0.75% residual activity at 1 mM for both isoforms GMD1 and GMD2
-
full reactivation by dithiothreitol (25 mM) after p-hydroxymercuribenzoate or iodoacetamide inactivation
-
additional information
-
strains which resist 0.005 mg/ml of tobramycin treated by 5'-(3-hydroxypropyl)-amino-5'-deoxy-guanosine, tetra-O-acetylmannopyranose and 5'[[[[(2'',3'',4'',6''-tetra-O-acetyl 6''-ethynyl)alpha-D-mannopyranosyl oxy]-carbonyl]amino]sulfonyl]-2',3'-isopropylidene N2-acetyl guanosine recover 20, 75 and 85% of their sensisivity towards tobramycin
-